The effect of arachidonic acid (AA) combined with UVA irradiation was studied in a model system mimicking phototherapy PUVA (psoralen+UVA) ex vivo in vitro. The contribution of damage to the plasma membrane by PUVA was tested on human lymphocytes derived from healthy donors. The effect of arachidonic acid (AA) combined with UVA irradiation was compared with that of a psoralen photoadduct to AA added to the culture. The adduct, obtained photochemically and purified, was characterized by NMR and MS spectrometry as a cycloadduct of psoralen to the vinylene bond of the acid (AA<>PSO).The reactions of cultured cells, manifested 20 h after treatment by changes in apoptosis and mitochondrial depolarization, were monitored by flow cytometry by tagging lymphocytes with appropriate fluorescent probes. Treatment of lymphocyte suspension within AA doses from 40 to 100 mM gradually induced a shift from Anx-V + (single positive cells) to late apoptotic, Anx-V + PI + (double positive cells) in a dose dependent manner. The adduct, AA<>PSO, induced apoptotic changes at a concentration 2-3 times higher than free AA. Combination of psoralen (1 mM ) or arachidonic acid (20-120 mM) with UVA irradiation (2-6 J/cm 2 ) accelerated theVol. 52 No. Abbreviations: AA, arachidonic acid; AA<>PSO, arachidonic-acid-psoralen-photoadduct; Anx-V, annexin V tagged with fluorescein isothiocyanate (FITC); JC-1, 5,5¢,6,6¢-tetrachloro-1,1¢,3,3¢-tetraethylbenzimidazolylcarbocyanine iodide; MMP, mitochondrial membrane potential; PI, propidium iodide; PLA2, phospholipase 2; PSO, psoralen; PUVA (psoralen+UVA); UVA, waveband of irradiation, (320-400 nm).